Gut microbiota metabolites and microbiota-targeted interventions in bone metabolism: from SCFAs and TMAO to probiotics and FMT
Postgraduate Medical Journal · 28.07.2026
DOI: 10.1093/postmj/qgag099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postgraduate Medical Journal, online erschienen am 28.07.2026. Verfasst von Zhihui Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedics Department, Jiaxing Xiuzhou District People's Hospital, Jiaxing, Zhejiang, 314000, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Accumulating evidence supports a microbiota-gut-bone axis in which intestinal microbes influence skeletal remodeling through barrier integrity, immune signaling, and metabolite production.
Methods
This review emphasizes specific metabolites, strain-level intervention data, and translational limitations.
Results
Preclinical studies consistently show that dysbiosis, barrier disruption, and altered microbial metabolites promote osteoclastogenesis and suppress osteoblast function. Among short-chain fatty acids, propionate and butyrate have the strongest direct anti-osteoclast evidence, whereas acetate a bone-relevant systemic substrate/signaling molecule with context-dependent skeletal effects. Trimethylamine N-oxide has been linked mechanistically to impaired osteogenic commitment of bone marrow stromal cells and inflammatory signaling, although human epidemiologic findings are not uniform. These mechanisms appear particularly relevant in postmenopausal osteoporosis and glucocorticoid-induced osteoporosis, where estrogen deficiency or glucocorticoid exposure amplifies intestinal permeability, inflammatory tone, and microbial dysbiosis. In humans, the clinical signal is promising but heterogeneous. Fecal microbiota transplantation remains largely preclinical in bone disease and faces major challenges in donor selection, protocol standardization, timing, and long-term safety.
Conclusions
Overall, the field is moving from associative observations toward causal and precision-oriented models, but large, well-phenotyped human studies integrating metagenomics, metabolomics, proteomics, and host clinical data are still needed before microbiota-targeted therapies can be routinely incorporated into osteoporosis care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orthopedics Department, Jiaxing Xiuzhou District People's Hospital, Jiaxing, Zhejiang, 314000, China.
- Orthopedics Department, Hubei Provincial Hospital of Integrated Chinese & Western Medicine, Wuhan, Hubei, 430015, China.
- Orthopedics Department, Wuhan University of Science and Technology, Geriatric Hospital Affiliated, Wuhan, Hubei, 430205, China.
- Orthopedics Department, Wuhan Jiangxia Hospital of Traditional Chinese Medicine , Wuhan, Hubei, 430200, China.
ORCID-Profile: Zhihui Huang
Zitieren
APA
Huang, Z., Li, Z., Wu, F., & Zhou, D. (2026). Gut microbiota metabolites and microbiota-targeted interventions in bone metabolism: from SCFAs and TMAO to probiotics and FMT. Postgraduate Medical Journal. https://doi.org/10.1093/postmj/qgag099
Vancouver
Huang Z, Li Z, Wu F, Zhou D. Gut microbiota metabolites and microbiota-targeted interventions in bone metabolism: from SCFAs and TMAO to probiotics and FMT. Postgraduate Medical Journal. 2026. doi:10.1093/postmj/qgag099
BibTeX
@article{Huang2026,
author = {Huang, Zhihui and Li, Zhigang and Wu, Fan and Zhou, Dabiao},
title = {Gut microbiota metabolites and microbiota-targeted interventions in bone metabolism: from SCFAs and TMAO to probiotics and FMT},
journal = {Postgraduate Medical Journal},
year = {2026},
doi = {10.1093/postmj/qgag099}
}
EUVIMED